 efficaci acebutolol acut myocardi infarct apsi trial apsi random placebo-control trial effect acebutolol late death high-risk patient acut myocardi infarct MI averag mortal rate placebo group trial beta blocker post-mi patient nonselect cohort patient day MI mandat trial fact high-risk patient mortal rate signific number previou trial beta-block therapi patient popul benefici select high-risk patient inclus trial algorithm essai prevent secondair myocard registri time second interim analysi mortal rate placebo group equal trial time patient patient therapi day death acebutolol-tr group placebo group reduct total mortal vascular death placebo group acebutolol group cardiovascular mortal acebutolol incid cardiovascular-rel death acebutolol-tr group total reduct mortal secondari risk factor